japanese korean simple chinese traditional chinese

Pre-Conference Workshop
Overview 
Day 1
Day 2
Distinguished Faculty
Register 
PDF Download
Hotel & Travel
Sponsor
Press Pass 
Request Brochure 

Complimentary Whitepaper

Partnering Best Practices for R&D Project Teams
William C. Ronco, Ph.D., President, Gathering Pace Consulting 

AppliedBiosystemsMDS logoPCC

Excel PharmaStudies

WilsonSonsini

Crownbio

Fountain Medical

ACRO

Asia Pacific

CABS

SABPA_2008

China Bio Accelerator

BioITWorld

Science AAAS

The Scientist

Asia Monitor

Business Monitor

Bio Outsourcing Asia

ChinaBio Today

China Business Review

Espicom

Future Pharmaceuticals

The Pink Sheet

The Pink Sheet Daily

Pharma Agreement News

PharmAsia News

Pharma_Company_Insight

Pharma Insight

Pharma China 

PharmaVoice

PharmaWeek

Reviews on Recent Clinical Trials

Thomson Reuters

Biolexis

CanBiotech

Pharmalicensing

PharmCast

SelectScience logo

 

Distinguished Faculty:

  • Li Chen, Ph.D., Chief Scientific Officer, Roche R&D Center (China) Ltd.
  • Ling Chen, Ph.D., Director General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences
  • Shaoyu Chen, Senior Counsel, Development & Regulatory Law Group, Amgen Inc.
  • Joong Myung Cho, Ph.D., President & CEO, CrystalGenomics, Inc. (South Korea)
  • Ming Guo, Ph.D., Vice President, Pharmaceutical Sciences & Manufacturing; General Manager, Ascenta (Shanghai) R&D Center; Ascenta Therapeutics, Inc.
  • Canwen Jiang, M.D., Ph.D., Head of Genzyme Science (R&D) China, Genzyme
  • Xian-Ping Lu, CEO & Chief Scientific Officer, Shenzhen Chipscreen Biosciences Ltd.
  • Eric Meyers, President, China Preclinical Management Services
  • Purvish M. Parikh, Ph.D., Professor, Medical Oncology, Indian Co-operative Oncology Network (ICON-ARO)
  • Rickey Pate, MBA, JD, Director of Global Tax, Eli Lilly and Company
  • Sofie Qiao, Ph.D., President and COO, LEAD Therapeutics, Inc.
  • Jun Ren, M.D., Ph.D., Executive Director, Clinical Trials Coordination, Peking University School of Oncology / Beijing Cancer Hospital
  • Greg B. Scott, President and Founder, ChinaBio® Accelerator/Life Science Angels
  • Michael Shi, Director and Biomarker Project Leader, Exploratory Oncology Development,  Novartis Oncology
  • Mansour Yaïch, Ph.D., Vaccine Development Director, PATH
  • Zhengyu Yuan, Ph.D., President and CEO, MicuRx Pharmaceuticals, Inc.
  • Benny Zee, Ph.D., Assistant Dean of Research for the Faculty of Medicine, Director of the Centre for Clinical Trials, School of Public Health, Chinese University of Hong Kong (CUHK)
  • Ji Zhang, Ph.D., Director, DMPK, GlaxoSmithKline R&D China
  • Haizhou Zhang, Ph.D., Vice President, China Operations, China Preclinical Management Services
  • Guoxin Zhu, Ph.D., CSO, Head of China Chemistry, Discovery Chemistry Research Technology, Eli Lilly Asia, Inc., Shanghai Rep. Office